Success rate of methotrexate treatment for recurrent vs. primary ectopic pregnancy: a case-control study

• Published in: Journal of obstetrics and gynaecology Vol. 40; no. 4; p. 507
• Main Authors: Levin, Gabriel, Dior, Uri P, Shushan, Asher, Gilad, Ronit, Benshushan, Avi, Rottenstreich, Amihai
• Format: Journal Article
• Language: English
• Published: England 18.05.2020
• Subjects: Abortifacient Agents, Nonsteroidal - administration & dosage; Abortifacient Agents, Nonsteroidal - adverse effects; Adult; Case-Control Studies; Chorionic Gonadotropin - blood; Drug Dosage Calculations; Drug Monitoring - methods; Female; Humans; Israel - epidemiology; Methotrexate - administration & dosage; Methotrexate - adverse effects; Pregnancy; Pregnancy, Tubal - blood; Pregnancy, Tubal - diagnosis; Pregnancy, Tubal - drug therapy; Pregnancy, Tubal - epidemiology; Recurrence; Risk Factors; Treatment Outcome; Israel; recurrent ectopic pregnancy; Ectopic pregnancy; methotrexate

The aim of this study was to compare the success rate of methotrexate (MTX) treatment in patients with recurrent ectopic pregnancy (REP) and primary EP (PEP). A retrospective cohort study. The study cohort comprised all patients diagnosed with an EP and treated by intention with single-dose regimen...